Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Xiao-Shuai Yuan"'
Autor:
Xiao-Shuai Yuan, Long-Xiang Cao, Ye-Ji Hu, Fei-Chao Bao, Zhi-Tian Wang, Jin-Lin Cao, Ping Yuan, Wang Lv, Jian Hu
Publikováno v:
Tumor Biology, Vol 39 (2017)
Lung cancer, of which non-small cell lung cancer accounts for 80%, remains a leading cause of cancer-related mortality and morbidity worldwide. Our study revealed that the expression of WD repeat containing antisense to P53 (WRAP53) is higher in lung
Externí odkaz:
https://doaj.org/article/3508f450a17a4a299d963767b66ccd61
Autor:
Ping Yuan, Jin-lin Cao, Abudumailamu Abuduwufuer, Lu-Ming Wang, Xiao-Shuai Yuan, Wang Lv, Jian Hu
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146803 (2016)
BACKGROUND:The prevalence of telomerase reverse transcriptase (TERT) promoter mutations (pTERTm) in non-small-cell lung cancer (NSCLC) have been investigated, but the results were inconsistent. In addition, several studies have analysed the role of p
Externí odkaz:
https://doaj.org/article/9deada905b5f4c63b30f5e462fb15258
Autor:
Wucheng Chen, Jinshi Liu, Yuan-Jun Liu, Xiao-Jiang Sun, Qingren Lin, Yaoyao Zhu, Qiong-Ya Wu, Yaping Xu, Xiao-Shuai Yuan
Publikováno v:
J Thorac Dis
Background To investigate the comparative effectiveness of stereotactic body radiotherapy (SBRT) and sublobar resection (SLR) in patients with stage I non-small cell lung cancer (NSCLC) considered to be high-risk lobectomy patients. Methods From Janu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143437ef490df1207014e528a033b11e
https://europepmc.org/articles/PMC8024811/
https://europepmc.org/articles/PMC8024811/
Autor:
Wu-Cheng Chen, Xiao-Shuai Yuan, Yuan-Jun Liu, Qing-Ren Lin, Xiao-Jiang Sun, Jin-Shi Liu, Ya-Ping Xu
Background: To investigate comparative effectiveness of stereotactic body radiotherapy (SBRT) and sublobar resection (SLR) in patients who had stage I non-small cell lung cancer (NSCLC) and a high risk for lobectomy.Methods: From January 2012 to Dece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc8a007f96dc9901e8bd032432af9d06
https://doi.org/10.21203/rs.3.rs-15907/v2
https://doi.org/10.21203/rs.3.rs-15907/v2
Autor:
Qingren Lin, Yaping Xu, Qian Li, Yefei Li, Qinghua Xu, Xiaojiang Sun, Denghu Weng, Xiao-Shuai Yuan, Hui Liu, Yaoyao Zhu
Publikováno v:
Transl Lung Cancer Res
Background Previous research has shown that stereotactic body radiation therapy (SBRT) can achieve a high level of tumor control in patients with early-stage non-small cell lung cancer (NSCLC). However, to date, such studies have mainly focused on pe
Publikováno v:
Journal of Clinical Oncology. 38:e21052-e21052
e21052 Background: For patients with unresectable stage III disease, combined modality therapy (chemoradiation) is superior to radiation alone, and concurrent chemoradiotherapy (CCRT) is superior to sequential chemoradiotherapy (SCRT). The current st
Autor:
Jin Lin Cao, Fei Chao Bao, Azmat Rustam, Chong Zhang, Ping Yuan, Jian Hu, Wang Lv, Xiao Shuai Yuan
Publikováno v:
Scientific Reports
The average time required for cancers to progress through stages can be reflected in the average age of the patients diagnosed at each stage of disease. To estimate the time it takes for non-small-cell lung cancer (NSCLC) to progress through differen
Publikováno v:
Journal of Hematology & Oncology
Exosomes have emerged as a novel mode of intercellular communication. Exosomes can shuttle bioactive molecules including proteins, DNA, mRNA, as well as non-coding RNAs from one cell to another, leading to the exchange of genetic information and repr